{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-158493","form_type":"8-K","ticker":"PRGO","cik":"0001585364","company_name":"PERRIGO Co plc","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.435439+00:00","generated_at":"2026-05-18T06:39:17.795729+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Perrigo to sell Dermacosmetics business to KKR for up to €327M","bullets":["Upfront cash €300M, plus up to €27M milestone payments over three years.","Divestiture includes brands ACO, Biodermal, Emolium, Iwostin; 2024 net sales ~€125M.","Expected to close Q1 2026; net proceeds to strengthen balance sheet.","Advances Perrigo's 'Three-S' plan to streamline portfolio and focus on high-growth brands.","Business generated ~5% of Perrigo's 2024 adjusted operating income."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-158493","json":"https://secwatch.observer/filing/0001193125-25-158493.json","markdown":"https://secwatch.observer/filing/0001193125-25-158493.md","text":"https://secwatch.observer/filing/0001193125-25-158493.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585364/000119312525158493/0001193125-25-158493-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585364/000119312525158493/d89351d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:39:17.795729+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}